Sort
48,018 grants matching “immunotherapy”
Body composition and the obesity paradox in clear cell renal cell carcinoma
$788,137Anna Helena Furberg-Barnes · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
CONTROL AND ACTIVATION OF THE TUMOR NECROSIS FACTOR RECEPTORS
$788,037James J Chou · Harvard Medical School · R01 · FY2022 · AI
Proteogenomic translator for cancer biomarker discovery towards precision medicine
$787,902Pei Wang · Icahn School Of Medicine At Mount Sinai · U24 · FY2024 · CA
CORE C Technology Implementation/Development and Correlative Sciences
$787,787Friederike Herbst-Nowrouzi · University Of Pennsylvania · P01 · FY2024 · CA
Project II: Immune regulatory circuits in primary colon cancer and lymph node and liver metastases
$787,650Alexander Y. Rudensky · Sloan-Kettering Inst Can Research · U54 · FY2022 · CA
High throughput screening assays to identify chemical probes targeting Hectd3, an E3 ubiquitin ligase implicated in multiple sclerosis
$787,248Hongmin Li · University Of Arizona · R01 · FY2022 · AI
High throughput screening assays to identify chemical probes targeting Hectd3, an E3 ubiquitin ligase implicated in multiple sclerosis
$787,248Hongmin Li · University Of Arizona · R01 · FY2023 · AI
High throughput screening assays to identify chemical probes targeting Hectd3, an E3 ubiquitin ligase implicated in multiple sclerosis
$787,248Hongmin Li · University Of Arizona · R01 · FY2024 · AI
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$787,127James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Clinical trials employing cancer vaccine combination therapies
$787,127James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
The cross-talk between a-Synucleinopathies and T cell immunity in ADRD
$787,127Xiaobo Mao · Johns Hopkins University · R01 · FY2025 · AG
Immunoprevention and immunosurveillance of human non-viral cancers
$786,933Olivera J Finn · University Of Pittsburgh At Pittsburgh · R35 · FY2022 · CA
Chemokine Modulation During SIV Infection & AIDS
$786,852Todd A Reinhart · University Of Pittsburgh At Pittsburgh · R01 · FY2007 · AI
Molecular Genetic Analysis of Mycobacterium Tuberculosis
$786,783William Robert Jacobs · Albert Einstein College Of Medicine · R37 · FY2024 · AI
Single-cell DNA methylation analysis of human cancer
$786,638Kenneth Aldape · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Brain myeloid cell-targeted multiplexed gene editing for SIV/HIV eradication
$786,365Binhua Ling · Texas Biomedical Research Institute · R01 · FY2024 · MH
System Dynamics of PD-1 Signaling in T Cells
$786,358William S. Hlavacek · Triad National Security, Llc · R01 · FY2025 · AI
Mammalian and Plant-derived Antibody-based Therapies against Sudan Ebolavirus
$786,345John M Dye · Geneva Foundation · R01 · FY2018 · AI
HIV Persistence and Renewal in the Gastrointestinal, Genitourinary and Adipose Tissues
$786,123David Mitchell Smith · University Of California, San Diego · R01 · FY2022 · DK
System Dynamics of PD-1 Signaling in T Cells
$785,898William S. Hlavacek · Triad National Security, Llc · R01 · FY2024 · AI
TARGETING IMMUNOTHERAPY-RESISTANT LESIONS TO ERADICATE OLIGOMETASTATIC PROSTATE CANCER
$785,833University Of Wisconsin System · · FY2024 · Defense Health Agency
Functions of KSHV microRNAs
$785,709Joseph Ziegelbauer · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
MHC Variation in Host Response to SARS-CoV2 and COVID-19 Outcomes
$785,611Jill Allison Hollenbach · University Of California, San Francisco · R01 · FY2025 · AI
Image-based models of tumor-immune dynamics in glioblastoma
$785,579Kristin R Swanson · Mayo Clinic Arizona · U01 · FY2021 · CA
Protective Human Monoclonal Antibodies to HIV-1
$785,373Susan B Zolla-Pazner · New York University School Of Medicine · R01 · FY2009 · HL